Atomistry » Potassium » PDB 5dkp-5f0g » 5dry
Atomistry »
  Potassium »
    PDB 5dkp-5f0g »
      5dry »

Potassium in PDB 5dry: Crystal Structure of DOT1L in Complex with Inhibitor CPD3 [N-(1-(2- Chlorophenyl)-1H-Indol-6-Yl)-2-(2-(5-(2-Chlorophenyl)-1H-Tetrazol-1- Yl)Acetyl)Hydrazinecarboxamide]

Enzymatic activity of Crystal Structure of DOT1L in Complex with Inhibitor CPD3 [N-(1-(2- Chlorophenyl)-1H-Indol-6-Yl)-2-(2-(5-(2-Chlorophenyl)-1H-Tetrazol-1- Yl)Acetyl)Hydrazinecarboxamide]

All present enzymatic activity of Crystal Structure of DOT1L in Complex with Inhibitor CPD3 [N-(1-(2- Chlorophenyl)-1H-Indol-6-Yl)-2-(2-(5-(2-Chlorophenyl)-1H-Tetrazol-1- Yl)Acetyl)Hydrazinecarboxamide]:
2.1.1.43;

Protein crystallography data

The structure of Crystal Structure of DOT1L in Complex with Inhibitor CPD3 [N-(1-(2- Chlorophenyl)-1H-Indol-6-Yl)-2-(2-(5-(2-Chlorophenyl)-1H-Tetrazol-1- Yl)Acetyl)Hydrazinecarboxamide], PDB code: 5dry was solved by C.Scheufler, C.Gaul, C.Be, H.Moebitz, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 45.83 / 2.41
Space group P 63
Cell size a, b, c (Å), α, β, γ (°) 158.760, 158.760, 74.460, 90.00, 90.00, 120.00
R / Rfree (%) 17.7 / 19.9

Other elements in 5dry:

The structure of Crystal Structure of DOT1L in Complex with Inhibitor CPD3 [N-(1-(2- Chlorophenyl)-1H-Indol-6-Yl)-2-(2-(5-(2-Chlorophenyl)-1H-Tetrazol-1- Yl)Acetyl)Hydrazinecarboxamide] also contains other interesting chemical elements:

Chlorine (Cl) 4 atoms

Potassium Binding Sites:

The binding sites of Potassium atom in the Crystal Structure of DOT1L in Complex with Inhibitor CPD3 [N-(1-(2- Chlorophenyl)-1H-Indol-6-Yl)-2-(2-(5-(2-Chlorophenyl)-1H-Tetrazol-1- Yl)Acetyl)Hydrazinecarboxamide] (pdb code 5dry). This binding sites where shown within 5.0 Angstroms radius around Potassium atom.
In total 2 binding sites of Potassium where determined in the Crystal Structure of DOT1L in Complex with Inhibitor CPD3 [N-(1-(2- Chlorophenyl)-1H-Indol-6-Yl)-2-(2-(5-(2-Chlorophenyl)-1H-Tetrazol-1- Yl)Acetyl)Hydrazinecarboxamide], PDB code: 5dry:
Jump to Potassium binding site number: 1; 2;

Potassium binding site 1 out of 2 in 5dry

Go back to Potassium Binding Sites List in 5dry
Potassium binding site 1 out of 2 in the Crystal Structure of DOT1L in Complex with Inhibitor CPD3 [N-(1-(2- Chlorophenyl)-1H-Indol-6-Yl)-2-(2-(5-(2-Chlorophenyl)-1H-Tetrazol-1- Yl)Acetyl)Hydrazinecarboxamide]


Mono view


Stereo pair view

A full contact list of Potassium with other atoms in the K binding site number 1 of Crystal Structure of DOT1L in Complex with Inhibitor CPD3 [N-(1-(2- Chlorophenyl)-1H-Indol-6-Yl)-2-(2-(5-(2-Chlorophenyl)-1H-Tetrazol-1- Yl)Acetyl)Hydrazinecarboxamide] within 5.0Å range:
probe atom residue distance (Å) B Occ
A:K401

b:0.1
occ:1.00
 O A:HOH614 2.5 83.3 1.0
O A:MET55 2.7 96.9 1.0
O A:HOH591 2.8 69.9 1.0
ND2 A:ASN57 3.4 0.3 1.0
O A:LEU53 3.7 96.6 1.0
O A:LYS52 3.8 94.2 1.0
CG A:ASN57 3.9 0.4 1.0
OD1 A:ASN57 4.0 0.0 1.0
C A:MET55 4.0 95.6 1.0
O A:HOH606 4.1 62.7 1.0
N A:ASN57 4.3 94.2 1.0
C A:LEU53 4.4 96.6 1.0
C A:GLU56 4.6 97.1 1.0
CA A:GLU56 4.7 94.8 1.0
CA A:ASN57 4.8 92.8 1.0
CA A:LEU53 4.8 93.8 1.0
N A:GLU56 4.8 93.6 1.0
N A:MET55 4.9 89.0 1.0
CB A:ASN57 4.9 95.7 1.0
C A:LYS52 4.9 93.8 1.0
O A:HOH572 4.9 77.8 1.0
CA A:MET55 5.0 87.9 1.0

Potassium binding site 2 out of 2 in 5dry

Go back to Potassium Binding Sites List in 5dry
Potassium binding site 2 out of 2 in the Crystal Structure of DOT1L in Complex with Inhibitor CPD3 [N-(1-(2- Chlorophenyl)-1H-Indol-6-Yl)-2-(2-(5-(2-Chlorophenyl)-1H-Tetrazol-1- Yl)Acetyl)Hydrazinecarboxamide]


Mono view


Stereo pair view

A full contact list of Potassium with other atoms in the K binding site number 2 of Crystal Structure of DOT1L in Complex with Inhibitor CPD3 [N-(1-(2- Chlorophenyl)-1H-Indol-6-Yl)-2-(2-(5-(2-Chlorophenyl)-1H-Tetrazol-1- Yl)Acetyl)Hydrazinecarboxamide] within 5.0Å range:
probe atom residue distance (Å) B Occ
B:K1001

b:67.3
occ:1.00
 O B:LYS52 2.5 50.8 1.0
O B:MET55 2.8 46.0 1.0
O B:LEU53 2.9 50.5 1.0
ND2 B:ASN57 3.2 87.9 1.0
O B:HOH1230 3.3 57.7 1.0
O B:HOH1222 3.3 52.0 1.0
C B:LEU53 3.4 47.5 1.0
O B:HOH1233 3.6 68.1 1.0
CA B:LEU53 3.6 43.6 1.0
C B:LYS52 3.6 48.0 1.0
C B:MET55 4.0 48.0 1.0
N B:LEU53 4.0 42.6 1.0
CG B:ASN57 4.1 96.9 1.0
N B:MET55 4.4 39.5 1.0
N B:ALA54 4.4 39.9 1.0
C B:ALA54 4.6 41.6 1.0
CB B:ASN57 4.6 65.7 1.0
O B:HOH1106 4.6 40.0 1.0
N B:ASN57 4.7 59.6 1.0
CA B:MET55 4.7 41.0 1.0
O B:ALA54 4.9 42.0 1.0
CA B:LYS52 4.9 42.7 1.0
CB B:LEU53 5.0 45.4 1.0
OD1 B:ASN57 5.0 94.3 1.0
N B:GLU56 5.0 50.2 1.0
CA B:ALA54 5.0 38.5 1.0

Reference:

C.Chen, H.Zhu, F.Stauffer, G.Caravatti, S.Vollmer, R.Machauer, P.Holzer, H.Mobitz, C.Scheufler, M.Klumpp, R.Tiedt, K.S.Beyer, K.Calkins, D.Guthy, M.Kiffe, J.Zhang, C.Gaul. Discovery of Novel DOT1L Inhibitors Through A Structure-Based Fragmentation Approach. Acs Med.Chem.Lett. V. 7 735 2016.
ISSN: ISSN 1948-5875
PubMed: 27563395
DOI: 10.1021/ACSMEDCHEMLETT.6B00167
Page generated: Mon Aug 12 13:17:14 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy